9 |
GLOBAL HUMAN INSULIN DRUGS MARKET , BY BRAND .......................................................... 73 |
||
• 9.1 |
INTRODUCTION ............................................................................................................................................................... 74 |
||
• 9.2 |
INSULIN ANALOGS AND BIOSIMILARS ........................................................................................................................... 75 |
||
• 9.2.1 |
LANTUS ......................................................................................................................................................... 77 |
||
• 9.2.2 |
NOVORAPID AND NOVOLOG ......................................................................................................................... 78 |
||
• 9.2.3 |
HUMALOG ..................................................................................................................................................... 79 |
||
• 9.2.4 |
OTHER BRANDS ............................................................................................................................................. 80 |
||
• 9.3 |
HUMAN INSULIN BIOLOGICS .......................................................................................................................................... 81 |
||
• 9.3.1 |
ACTRAPID , MIXTARD , AND INSULATARD ..................................................................................................... 83 |
||
• 9.3.2 |
HUMULIN ....................................................................................................................................................... 84 |
||
• 9.3.3 |
INSUMAN ....................................................................................................................................................... 85 |
||
10 |
GLOBAL HUMAN INSULIN MARKET , BY DELIVERY DEVICE ..................................................... 86 |
||
• 10.1 |
INTRODUCTION ............................................................................................................................................................... 87 |
||
• 10.2 |
HUMAN INSULIN PENS ................................................................................................................................................... 88 |
||
• 10.2.1 |
REUSABLE PENS ........................................................................................................................................... 89 |
||
• 10.2.2 |
DISPOSABLE PENS ........................................................................................................................................ 90 |
||
• 10.3 |
HUMAN INSULIN PEN NEEDLES ..................................................................................................................................... 91 |
||
• 10.3.1 |
STANDARD PEN NEEDLES ............................................................................................................................. 92 |
||
• 10.3.2 |
SAFETY PEN NEEDLES .................................................................................................................................. 93 |
||
• 10.4 |
HUMAN INSULIN SYRINGES ........................................................................................................................................... 94 |
||
11 |
GLOBAL HUMAN INSULIN MARKET , BY APPLICATION ............................................................. 95 |
||
• 11.1 |
INTRODUCTION ............................................................................................................................................................... 96 |
||
• 11.2 |
TYPE I DIABETES ............................................................................................................................................................. 96 |
||
• 11.3 |
TYPE II DIABETES ............................................................................................................................................................ 97 |
||
• | |||